SCHEMBL5132632

SCHEMBL5132632

COC(CNC(=O)OC(C)(C)C)Cn1c(=O)c2c(C)[nH]nc2c2cc3c(cc21)CCCC3

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 11/20 0.46
KCNH2 Q12809 2/20 0.42
SERPINE1 P05121 1/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
GFER P55789 2/20 0.31
PLK1 P53350 1/20 0.31
HSD17B10 Q99714 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
DYRK1A Q13627 1/20 0.30
AURKA O14965 1/20 0.30
KDR P35968 1/20 0.30
AURKB Q96GD4 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4017815 0.89 CHEK1 (0.50) CHEK1KCNH2KDM4ELMNAGFER
SCHEMBL5129531 0.82 CHEK1 (0.53) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL5128333 0.81 PTGDR2 (0.35) KDM4ELMNAL3MBTL1CYP1A2CYP2D6
SCHEMBL5123971 0.74 CHEK1 (0.57) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL4016551 0.74 CHEK1 (0.70) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL4016550 0.74 CHEK1 (0.70) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL4017264 0.74 CHEK1 (0.70) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL4023100 0.74 CHEK1 (0.33) CHEK1KCNH2KDM4ELMNAHSD17B10
SCHEMBL4014749 0.74 CHEK1 (0.33) CHEK1KCNH2KDM4ELMNAHSD17B10
SCHEMBL4017813 0.74 CHEK1 (0.33) CHEK1KCNH2KDM4ELMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080114016-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2008-05-15 US disclosed
US-20080114016-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2008-05-15 US disclosed
EP-1835918-A2 INHIBITORS OF CHECKPOINT KINASES Merck & Co., Inc. (US) 2007-09-26 EP disclosed
WO-2006074281-A2 INHIBITORS OF CHECKPOINT KINASES MERCK & CO., INC. (US) 2006-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114016-A1 Inhibitors of Checkpoint Kinases CHEK1, CHEK2, BUB1B CHEK1 1/4885KCNH2 3426/4885SERPINE1 2613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.